
Samuel Gray Deem DO MBA, FACOS
Minimally Invasive Surgery, Surgical Oncology
Director of Robotic Surgery Urology Residency Program Director
Join to view full profile
3100 Maccorkle Ave SeSuite 602Charleston, WV 25304
Phone+1 304-388-5280
Fax+1 304-388-5291
Dr. Deem is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samuel Deem, DO, based in Charleston, WV, specializes in urology with a focus on minimally invasive surgery and surgical oncology. He completed a fellowship in urologic surgical oncology at the Medical University of South Carolina and a urology residency at Charleston Area Medical Center. Dr. Deem is experienced in urologic oncology, minimally invasive surgery, kidney and ureteral stones management, robotic surgery, and prostatectomy. He has authored several publications in esteemed journals, including Urologic Oncology and The Journal of Urology. His clinical trial involvement includes studies on cystectomy procedures and ureteral stent size measurement. Dr. Deem has received multiple CMS Meaningful Use Stage Stage 2 Certifications for his use of healthcare technology.
Education & Training
Medical University of South CarolinaFellowship, Urologic Surgical Oncology, 2010 - 2011
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Urology, 2006 - 2010
UPMC Medical Education (Harrisburg) CommunityResidency, Surgery, 2004 - 2006
West Virginia School of Osteopathic MedicineClass of 2004
Certifications & Licensure
WV State License 2006 - 2028
SC State License 2010 - 2011
OH State License 2009 - 2010
PA State License 2004 - 2006
AOA Board of Surgery Urological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification MobileMD Patient Portal, Cerner Health Services, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification MobileMD Clinical Portal, Cerner Health Services, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification NextGen EDR, NextGen Healthcare, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Not Yet Comparable to Curative Standards.Amy R Deipolyi, Samuel Deem, Ronald S Arellano
The Journal of Urology. 2026-01-01 - 1 citationsLong-term Outcomes of Partial Nephrectomy Versus Percutaneous Ablation for Renal Cell Carcinoma: A Propensity-Matched Analysis.Madison Stamper, Jennifer Collins, Ronald S Arellano, Matthew DeSanto, Samuel Deem
Urology. 2025-12-01 - 2 citationsRepeat TURBT for Ta and T1 bladder cancer: An updated review.Matthew DeSanto, Jordan Campanelli, Samuel Deem
Urologic Oncology. 2025-11-01
Press Mentions
CAMC Urology First in West Virginia to Treat Prostate Cancer Using Advanced Ultrasound TechnologyJuly 20th, 2023
Charleston Area Medical Center Adds New Single-Port daVinci Surgery Robot to Assist with SurgeryApril 5th, 2024
Vandalia Health CAMC Greenbrier Valley Medical Center Unveils Surgical RobotJuly 19th, 2026
Professional Memberships
- Member
- Member
- Member
- American Urological AssocitionMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









